TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity-Reference-Cited by-同舟云学术

TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity

Published:2007-03-28 Issue:7138 Volume:446 Page:916-920
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Gack Michaela U.,Shin Young C.,Joo Chul-Hyun,Urano Tomohiko,Liang Chengyu,Sun Lijun,Takeuchi Osamu,Akira Shizuo,Chen Zhijian,Inoue Satoshi,Jung Jae U.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature05732.pdf

Reference21 articles.

1. Honda, K., Takaoka, A. & Taniguchi, T. Type I interferon gene induction by the interferon regulatory factor family of transcription factors. Immunity 25, 349–360 (2006); erratum 25, 849 (2006).

2. Hornung, V. et al. 5′-Triphosphate RNA is the ligand for RIG-I. Science 314, 994–997 (2006)

3. Meylan, E. & Tschopp, J. Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. Mol. Cell 22, 561–569 (2006)

4. Pichlmair, A. et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314, 997–1001 (2006)

5. Stetson, D. B. & Medzhitov, R. Antiviral defense: interferons and beyond. J. Exp. Med. 203, 1837–1841 (2006)

Cited by 1388 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TRIM103 activates the RLRs pathway to enhance antiviral response by targeting VP5 and VP7;Developmental & Comparative Immunology;2024-12

2. Viral myocarditis: From molecular mechanisms to therapeutic prospects;European Journal of Pharmacology;2024-11

3. ZCCHC3 and Efp coordinately contribute to the pathophysiology of triple-negative breast cancer by modulating NCAPH;Biochemical and Biophysical Research Communications;2024-11

4. The E3 ligase ASB3 downregulates antiviral innate immunity by targeting MAVS for ubiquitin-proteasomal degradation;Cell Death & Differentiation;2024-09-12

5. Receptors and Host Factors for Enterovirus Infection: Implications for Cancer Therapy;Cancers;2024-09-12